Rick Simpson Oil (RSO) in Schuyler County, Illinois: The Complete Guide by OilWell Cannabis

Schuyler County sits in the heart of western Illinois—7,000 strong, surrounded by rolling cornfields that stretch to the horizon, where the Mississippi River defines our western border and the spirit of self-reliance runs deep in towns like Rushville, Browning, and Augusta. Out here, when the nearest specialist is a 90-minute drive to Springfield or Quincy, and when the local pharmacy’s hours don’t always line up with a farmer’s sunrise-to-sunset schedule, people learn to ask hard questions and find their own answers.

If you’re reading this from Schuyler County—maybe from a farmhouse outside Littleton, maybe from a quiet street in Camden—you’ve probably heard whispers about Rick Simpson Oil. Maybe a neighbor mentioned it at the co-op. Maybe you saw something online while searching “cannabis oil for pain Rushville Illinois” at 2 a.m. Maybe you’re a veteran back from deployment, dealing with memories that won’t quiet down, or you’re caring for a loved one whose cancer treatment left them nauseated and sleepless. Whatever brought you here, we wrote this for you.

We are OilWell Cannabis, a Houston-based company built from the ground up by someone who understands what it means to be let down by the system and to find answers in unexpected places. Our founder, Colin Valencia, grew up in one of the most dangerous border regions in America, where he learned to make cannabis products that actually work because people’s lives depended on it—first his dog Bentley, then himself. We’ve been featured seven times by ABC13 Houston, Texas’s number-one news source, because when reporters need someone who tells the truth without hype, they call us.

This guide is different from anything you’ll find on Schuyler County Google searches. We don’t just sell RSO—we publish our exact formulas so you can make it yourself if you need to. We don’t promise miracles, but we do promise honesty, because that’s what our neighbors in Schuyler County deserve.

Understanding Rick Simpson Oil: What Schuyler County Needs to Know

Who Is Rick Simpson?

Rick Simpson was born in 1949 in Amherst, Nova Scotia, Canada. He wasn’t a doctor or scientist—he was a power engineer and maintenance worker, a blue-collar tradesman like many of the folks who keep Schuyler County running. His story began with suffering. In 1997, while working at a hospital in Moncton, he fell from scaffolding and suffered a serious head injury. The aftermath included persistent tinnitus, dizziness, and post-concussion symptoms that conventional medicine couldn’t fix. He tried prescription medications that either didn’t help or made things worse. When he asked his doctor about cannabis, the answer was no.

Sound familiar? If you’re in Schuyler County and you’ve ever had a workplace injury—maybe on a farm, maybe in construction—and the pills just made you groggy or sick, you’ve lived a version of Simpson’s story.

Simpson’s interest in concentrated cannabis oil deepened after he learned about a 1974 NIH-funded study at the Medical College of Virginia, where THC was reported to slow or shrink tumors in mice. That study—originally intended to show harm—became Simpson’s touchstone, even though its findings were never replicated in controlled human cancer trials.

The pivotal moment came in 2003. Simpson reported that three bumps on his arm, diagnosed as basal cell carcinoma, disappeared after he applied concentrated cannabis oil and covered them with bandages for four days. No independent medical verification exists—no biopsy confirmation, no published case report, no clinical follow-up in any peer-reviewed source. This was his personal testimony, not medical evidence, but it became the origin story of Rick Simpson Oil.

Important context: Simpson’s account is presented here as personal testimony, not medical proof. The absence of clinical documentation means these events cannot be evaluated as medical evidence. Yet they are historically significant as the catalyst for a global movement around concentrated cannabis oil—one that eventually reached rural communities like Schuyler County.

The Crusade: How RSO Became a Movement

After 2003, Simpson committed himself to producing and distributing concentrated cannabis oil, giving it away for free to cancer patients and others in his community in Maccan, Nova Scotia. He charged nothing. By his account, he helped dozens of people with conditions including cancer, chronic pain, diabetes, infections, glaucoma, arthritis, depression, and insomnia—conditions that affect people in every corner of Schuyler County.

His story reached millions through the 2005 documentary Run From the Cure, which became foundational in cannabis circles worldwide. Many people in Schuyler County first learned about RSO through this film or online communities that shared it.

But Simpson’s advocacy brought him into direct conflict with Canadian law. The RCMP raided his property in 2005 and 2009. He was charged with cultivation, possession, and trafficking. Facing continued legal pressure, he eventually left Canada for Europe, living in Croatia and the Netherlands, where he continued his advocacy from abroad.

In 2012, he published Phoenix Tears: The Rick Simpson Story and maintained phoenixtears.ca as his information platform.

Throughout his public career, Simpson maintained an uncompromising position: cannabis oil—particularly high-THC oil made his way—could cure cancer and many other diseases. He believed pharmaceutical companies, government agencies, and medical institutions were actively suppressing this knowledge.

Important context: Simpson’s conspiratorial framing reflects a worldview shared by many in the early cannabis movement. It’s relevant to understanding RSO’s cultural significance, especially in politically conservative areas like Schuyler County where institutional distrust runs deep for historical reasons. We present his perspective without endorsement or dismissal, but we return to evidence throughout.

The Traditional RSO Protocol: Simpson’s 60-Gram, 90-Day Regimen

Simpson’s core recommendation was to consume 60 grams of concentrated cannabis oil over approximately 90 days. This protocol was designed for cancer but was applied to many conditions.

Goal

Consume 60 grams of high-THC cannabis oil over about 90 days. Simpson considered this the minimum for serious cancer treatment.

Titration Schedule

• Week 1: Dose the size of half a grain of rice (10-15 mg of oil) three times daily. Total: ~30-45 mg per day.
• Weeks 2-5: Double the dose every four days. By week five, reach ~1 gram (1,000 mg) per day, divided into three doses.
• Weeks 5-12: Maintain 1 gram per day until all 60 grams are consumed.

Administration Methods

• Oral (primary): Place under tongue or swallow. Simpson considered this essential for internal cancers.
• Topical (secondary): Apply directly to skin cancers, cover with bandage, change every 3-4 days.
• Inhalation (not primary): Acknowledged for immediate symptom relief (pain, nausea) but not for sustained treatment.

Tolerance and Psychoactive Effects

• Simpson claimed patients develop tolerance to THC’s psychoactive effects within 3-4 weeks.
• He recommended initial doses at night to sleep through the high.
• He warned against driving during titration.

Post-Protocol Maintenance

After completing 60 grams, Simpson recommended 1-2 grams per month indefinitely for long-term health and cancer prevention.

Dietary and Lifestyle Recommendations

Simpson advocated reducing sugar and processed foods, though his dietary advice was general compared to his detailed oil protocol.

Important Context for Evaluating This Protocol

This protocol was designed by one person based on personal experience, not clinical trials. Critical points:

• No controlled trial validation. No published randomized controlled trials, cohort studies, or well-documented case series evaluate this specific protocol for any condition.
• Assumes crude, unstandardized material. The 60-gram quantity assumes a single-strain, THC-dominant extract with no standardized potency. Actual THC content varied wildly.
• Very high THC exposure. At peak dosing, patients consumed ~1 gram of high-THC oil daily. Assuming 60-90% THC, that’s 600-900 mg of delta-9 THC per day—far exceeding anything studied clinically. For context, the FDA-approved drug dronabinol is typically dosed at 2.5-20 mg per day.
• Real risks at these doses. Consuming 600-900 mg of THC daily carries serious risks: severe intoxication, impairment, anxiety, panic, tachycardia, hypotension, and cannabis use disorder. These risks are well-documented in medical literature.
• Oncology context. Cancer patients are medically complex. Using unregulated, unstandardized cannabis oil as primary treatment—potentially in place of proven therapies—introduces harm beyond the oil itself.

What Is Traditional Rick Simpson Oil—The Product?

Traditional RSO was defined by Simpson’s method, not lab specs. Here’s what it actually was:

Source Material: High-THC, indica-dominant cannabis strains. No standardization—starting material varied by availability and season.

Extraction Solvent: Naphtha (petroleum-based) or 99% isopropyl alcohol. Neither is food-grade. Naphtha may contain benzene, toluene, and other toxic compounds.

Extraction Process:

1. Cannabis in a bucket
2. Cover with solvent, agitate
3. Filter through cheesecloth
4. Repeat with fresh solvent
5. Evaporate solvent in a rice cooker
6. Transfer thick oil to syringes

Appearance: Nearly black, thick, tar-like, sticky oil with strong cannabis odor and possible solvent-residual smell.

Cannabinoid Profile:

• Fully decarboxylated delta-9 THC (60-90% estimated)
• Minor cannabinoids at natural ratios, uncontrolled and unmeasured
• No lab verification

Terpene Content: Minimal to none. Solvent and heat destroyed terpenes.

Standardization and Testing: None. Every batch was different. No COA, no contaminant screening.

Residual Solvent Risk: Significant. Incomplete purging leaves potentially harmful residues. Modern extraction uses food-grade ethanol or CO₂ to address this.

Simpson’s Claims vs. The Evidence Record

Simpson claimed RSO could cure cancer and many other diseases. Let’s evaluate this against actual evidence.

What Simpson Was Not

He had no formal medical, pharmacology, or research training. He never conducted or published a clinical trial. His evidence was personal experience and testimonials—no controls, no verification, no follow-up.

What the Preclinical Literature Shows

• In vitro studies show THC and CBD can induce apoptosis, inhibit proliferation, and reduce angiogenesis in certain cancer cell lines.
• Animal studies show some tumor-growth inhibition.
• These findings are scientifically interesting but have not translated to proven human cancer cures.

What the Preclinical Literature Does NOT Show

No human clinical trial has demonstrated that RSO or any cannabis oil cures cancer. The gap between lab results and human outcomes is vast.

Institutional Positions

• National Cancer Institute (NCI): Acknowledges cannabinoid anticancer research in labs and animals but does not endorse cannabis as cancer treatment.
• FDA: Has not approved any cannabis plant product for cancer. Only purified CBD (Epidiolex) and synthetic THC analogues (dronabinol/nabilone) have specific approvals.
• Health Canada: Never approved RSO for cancer.
• NCCIH: Strongest evidence is for rare epilepsies, chemo nausea, and HIV/AIDS appetite—not cancer cure.

What Simpson Got Right

He drew attention to cannabinoids as serious biomedical research when the world ignored them. His advocacy helped create conditions for the legal cannabis industry. The term “RSO” remains the most recognized name for full-spectrum cannabis extract.

What He Overstated

The leap from preclinical signals to cancer cure was not supported by human evidence then, and it’s not supported now. Encouraging patients—especially cancer patients—to rely on RSO instead of proven therapies (surgery, radiation, chemo, immunotherapy) carries genuine harm potential. Delayed treatment is a documented concern.

The Legacy of Rick Simpson and Modern RSO

Today, “RSO” is used loosely across the legal cannabis industry. Many products labeled RSO bear little resemblance to Simpson’s original. In dispensaries, RSO can refer to almost any full-spectrum extract in a syringe.

Simpson himself criticized commercial products that depart from his method and philosophy. He believed in DIY, free-access medicine—grow your own, make your own, give it away. The modern industry commercialized what he distributed for free.

This philosophical tension matters in Schuyler County. We know many of you value self-reliance and distrust corporate gatekeeping. We get it. That’s why we publish our formulas. But we also believe in quality control, lab testing, and dosing precision—things Simpson never had. Whether you see that as improvement or betrayal depends on your perspective.

Traditional RSO vs. Modern Formulated RSO

Dimension	Traditional RSO	OilWell Formulated RSO
Source Material	Single high-THC indica strain	Multi-cannabinoid blend from multiple sources
Extraction	Naphtha or isopropyl alcohol	Food-grade ethanol or CO₂ methods
Cannabinoid Profile	THC-dominant, uncontrolled	Seven defined cannabinoids at specific ratios
Terpene Content	Destroyed by heat	Live terpenes at 5% with defined seven-terpene profile
Standardization	None—every batch different	Lab-tested with specific mg/mL targets (553 mg/mL)
Lab Testing	Not performed	Full panel testing for potency, terpenes, pesticides, heavy metals, residual solvents, microbial
Residual Solvents	Significant risk with naphtha	Controlled and tested
Dosing Precision	Approximate syringe-based	Measured per mL with known cannabinoid content
Product Formats	Single thick oil only	Sublingual oil and vape cartridge
THCa Preservation	No—fully decarboxylated	Yes—THCa included as separate ingredient at 1,500 mg
Evidence Approach	Anecdotal, personal testimony	Research-backed, evidence-weighted

Why OilWell’s Formulas Diverge from Traditional RSO

Our formulas are not traditional RSO. They are informed by the tradition but depart deliberately:

Multi-Cannabinoid Approach: Traditional RSO used whatever single strain was available. Our formulas include seven cannabinoids—CBD, CBG, delta-8 THC, THCa, delta-9 THC, CBN, CBC—because the entourage-effect literature suggests potential benefit from diversity, even though robust clinical proof remains limited [20][29].

Terpene Preservation: Traditional RSO had essentially no terpenes. We include live terpenes at 5% with a specific seven-terpene profile because terpene bioactivity is plausible and supported at the preclinical level [20][21][23][24][25][26][27][28][29].

THCa as Separate Ingredient: Traditional RSO fully decarboxylated everything. Our sublingual formula includes THCa at 1,500 mg, preserving the acidic precursor because the THCa literature suggests potentially relevant non-psychoactive bioactivity [12].

Reduced Delta-9 THC Dominance: Traditional RSO was 60-90% delta-9 THC. Our sublingual formula uses only 90 mg delta-9 THC, distributing the rest across other cannabinoids to reflect broader research.

Product Format Innovation: Simpson envisioned only oral oil. We offer sublingual oil and vape cartridge, each with format-specific formulation acknowledging different pharmacokinetic profiles [14].

Solvent Safety and Extraction Evolution

Traditional RSO used naphtha or isopropyl alcohol—neither food-grade. Naphtha contains benzene, toluene, and other toxic compounds. Incomplete purging leaves harmful residues.

Modern extraction uses food-grade ethanol or supercritical CO₂, allowing complete solvent removal and testing via validated methods like headspace gas chromatography. This is one of the clearest improvements over traditional RSO.

The Decarboxylation Question

Traditional RSO was fully decarboxylated. The rice cooker’s heat (60-80°C for naphtha, ~82°C for isopropyl alcohol) converted all THCa to delta-9 THC. Acidic cannabinoids were lost.

Our sublingual formula preserves THCa at 1,500 mg. This matters because THCa itself doesn’t produce psychoactive effects, but heating converts it to THC [12]. You control whether it stays non-psychoactive or becomes activated.

Terpene Loss in Traditional RSO

Terpenes volatilize at 21-157°C. Traditional RSO’s solvent evaporation destroyed them. Our formulas specify live terpenes at 5%: limonene, myrcene, caryophyllene, pinene, linalool, humulene, and terpinolene. The entourage-effect literature provides theoretical framework for why this matters [20][29].

Evidence Standards Then and Now

Rick Simpson operated pre-legalization, pre-testing. His evidence was anecdotal. This document uses formal evidence hierarchy: human clinical evidence first, then systematic reviews, then institutional summaries, then preclinical literature [1]-[29].

We honor the historical origin of RSO while committing to modern cannabinoid science standards. Where Simpson relied on testimony, we rely on published literature.

Simpson’s Protocol vs. Modern Dosing Considerations

Simpson’s protocol was designed around crude, single-strain extract. Direct comparison to our standardized, multi-cannabinoid formulation isn’t straightforward.

Key differences:

• Our sublingual formula delivers 553 mg/mL across seven cannabinoids vs. traditional RSO’s unknown/variable potency
• Our delta-9 THC is only 90 mg total vs. Simpson’s 600-900 mg/day
• Our product includes defined terpenes; traditional RSO had none

Future dosing guidance for our products should be developed independently of Simpson’s protocol, informed by per-compound evidence in GENERAL KNOWLEDGE and responsible titration principles.

About OilWell Cannabis and the OilWell RSO Formula

The Origin of OilWell Cannabis

OilWell Cannabis was founded by Colin Valencia in Houston, Texas. Colin grew up in McAllen, Texas—right across the river from Reynosa, Tamaulipas, Mexico. The McAllen-Reynosa area, known as the Borderplex, is one of the most economically challenged and dangerous regions along the U.S.-Mexico border. McAllen is a city of contrasts—vibrant culture and thriving retail, yet deeply affected by poverty and limited opportunities outside retail and healthcare. Reynosa is an industrial hub plagued by violence and cartel activity.

Colin’s childhood was marked by exposure to both opportunities and challenges. Early on, he learned to hustle, taking on risky work transporting items across the border. Those experiences exposed him to complexities and dangers. A lot of his best friends have been killed or are in prison. He has faced every form of violence imaginable, both in the streets and across the border. By sixteen, one way or another, he had to leave home for good.

Despite the dangers, Colin did not fall into darker paths like selling harder substances. Instead, he focused on cannabis, seeing it as a safer and more beneficial alternative. He grew up in the traditional cannabis world long before legalization, learning the plant intimately while operating in the shadows. Over time, he transitioned from those early, risky ventures to creating a legal, legitimate business in an industry he believes in.

Colin later became a formally trained software engineer and did custom development work for Baylor College of Medicine, one of the most prestigious medical institutions in the Texas Medical Center. That combination—deep cannabis plant knowledge plus medical-grade technical precision—defines OilWell’s approach.

This matters for Schuyler County because we’re not a corporate cannabis chain. We’re a company built by someone who understands hardship, who learned to make medicine that works because lives depended on it.

Bentley’s Story: The Foundation

The company’s origin story begins with a dog named Bentley. Bentley was more than a pet—he was family, a companion who stood by Colin through the toughest times. When Bentley fell seriously ill, veterinarians delivered the verdict no pet owner wants: euthanasia was the only humane option. Bentley was paralyzed in his back legs. They said pain medications would destroy his internal organs, causing more suffering. The choice was painful prolonged decline or immediate mercy killing.

But giving up on Bentley was not an option. In a desperate search for alternatives, Colin stumbled upon CBD through a question that changed everything.

A rescue worker named Jessica asked: “You’ve moved how many tons of weed and you’ve never heard of CBD?”

Colin had cannabis experience—but it was recreational. He had never explored therapeutic applications. Jessica’s question exposed a blind spot that became a mission.

Determined to save Bentley, Colin learned to create CBD golden paste. It was not a cure, but it was a lifeline—and it was hope. That hope delivered what veterinary medicine said was impossible: Bentley got up, walked over to Colin, and brought him his ball to play. From paralyzed and facing euthanasia to fetching his ball. Dogs don’t respond to placebo. This was cannabinoid medicine doing what pharmaceuticals could not.

Bentley lived another ten years, passing naturally at age twenty. During those years, Colin developed specialized cannabis formulas for every age-related condition Bentley faced:

• Neurodegeneration led him to understand CBG’s neuroprotective properties and THCa’s PPARγ agonism for brain cell protection
• Dementia led him to CBC’s role in neurogenesis
• Glaucoma led him to THC’s CB1 agonism for intraocular pressure reduction
• Crippling arthritis led him to develop multi-pathway anti-inflammatory approaches using CBD, CBG, THCa, and beta-caryophyllene working through different receptor systems simultaneously

Single cannabinoids were not enough. Bentley’s evolving conditions required multi-cannabinoid synergy. Pharmaceutical precision mattered—Bentley’s life depended on formula accuracy, not guesswork.

If you’re in Schuyler County with a aging pet you love like family, or if you’re dealing with multiple health issues yourself, you understand why one compound can’t address everything.

Colin’s Personal Journey: PTSD and Benzo Addiction

Colin also knows pharmaceutical dependence personally. He struggled with PTSD and benzodiazepine addiction. When he decided to break free from Xanax, he did it cold turkey—a feat notoriously difficult and dangerous—using the cannabinoid knowledge he developed keeping Bentley alive.

The Peace Gummies formula that became an OilWell product was created during midnight experiments while fighting through benzo withdrawal. To ensure quick relief, OilWell also offers the Peace Gummies formula in a vape form, which Colin personally uses to manage his insomnia and severe PTSD. This is not theoretical knowledge. Colin lived what RSO patients live: desperation for relief, failed pharmaceuticals, the discovery that cannabinoids work when pills do not.

If you’re a veteran in Schuyler County dealing with PTSD, or anyone who’s been trapped in a prescription cycle that didn’t work, you’re not alone. We’ve been there.

Formulas Used by Doctors

Over time, the therapeutic benefits Colin discovered through Bentley became the core of his work. He has developed formulas that doctors use for conditions like Crohn’s disease, IBS, ulcerative colitis, PTSD, benzo addiction, and insomnia. His focus has always been on making cannabis accessible and effective for everyone, including vegans, diabetics, and those with specific health needs.

ABC13: Houston’s Go-To Cannabis Authority

Between September 2019 and April 2023, ABC13 Houston (KTRK) featured Colin Valencia and OilWell Cannabis in seven distinct news segments spanning business, law, medicine, community health, and politics. Five different reporters sought Colin out: Tom Abrahams, Steve Campion, Shelley Childers, Nick Natario, and KTRK staff writers. No other Houston cannabis operator appears with that frequency or breadth.

September 15, 2019: Texas CBD businesses booming
Colin’s foundational quote: “I’m not trying to sell people snake oil. I’m not trying to sell people hope, but there’s enough research out there that people just need to know and try and have the best possible version to base their opinions off of to give it a fair shot as to whether it’s right or wrong for them.”

This quote—from 2019, years before our formulas were published—is the seed of everything we became.

March 22, 2021: Decriminalization efforts
Colin’s therapy quote: “Pain comes in a lot of different forms.”

May 24, 2021: Delta-8 THC “Legal Weed”
Steve Campion’s iconic exchange: “Why would someone want to smoke that?” Colin: “I don’t give a sh* if it’s wrong to say you’ll get high off it. Maybe you want to get high.”* Radical honesty on mainstream television.

August 20, 2021: COVID vaccine giveaway
OilWell gave away 1,000 caviar pre-rolls (approximately $35,000 in product) to encourage vaccination, coordinated with the city of Houston. No political strings attached.

October 19, 2021: Delta-8 ban
When Texas DSHS classified Delta-8 as Schedule I overnight, Colin proactively removed all products before enforcement and warned other operators who were unknowingly shipping Schedule I narcotics. He absorbed a major revenue loss to act ethically.

October 7, 2022: Biden marijuana pardon
The feature revealed Colin’s personal marijuana conviction history. He said: “I would love to see people not get hurt for this anymore.” This personal history transforms the entire media record—every quote carries more weight when you know the person saying it has lived the consequences.

April 21, 2023: Texas marijuana laws
Colin’s “Renaissance” framing: “Right now is actually a pretty—like Renaissance—pretty important time that should be enjoyed now.”

These features are not marketing materials. They are independently produced, editorially controlled news segments from a major-market ABC affiliate that repeatedly identified Colin as the most credible voice in Houston’s legal cannabis industry. That kind of recognition cannot be purchased—it can only be earned.

Current Operations

Today, OilWell Cannabis operates from Montrose, Houston, Texas (810 Richmond Avenue, Houston, TX 77006). We’ve been operating since 2019, generate approximately one million dollars in annual revenue, maintain a near-5.0 Google rating, and are Texas DSHS licensed. Our products are not mass-produced—they are carefully crafted with a personal touch, from the artwork on the packaging to the formulations inside. All artwork, formulations, and packaging are created in-house in Houston, using only our own recipes and ideas.

The OilWell RSO Philosophy

Our RSO is not traditional RSO. It is a formulated, multi-cannabinoid product informed by the RSO tradition but departing from it in deliberate, evidence-motivated ways.

1. Accessibility over gatekeeping. No medical card required. Anyone age 21+ can purchase. We ship nationwide and internationally to customers who verify local legality. Simpson believed medicine should be accessible; we built a product and distribution model that makes that accessible legally—even to rural communities like Schuyler County where the nearest dispensary might be hours away.

2. Patient-controlled potency. THCa is sold in its acidic, non-psychoactive form. You decide whether to use it raw for non-psychoactive benefits or decarboxylate it into delta-9 THC for full psychoactive potency. Simpson believed patients should control their medicine; we engineered a product that puts that control in your hands through chemistry.

3. Open-source formulas. We publish our complete formulas publicly—every cannabinoid, every milligram, every percentage—so that anyone who cannot afford the product can source ingredients and make their own version. Simpson gave his oil away free and taught people how to make it; we adapted that ethos for the modern marketplace.

4. Evidence-informed, not evidence-overstating. The GENERAL KNOWLEDGE section in this document represents our commitment to honest education about what science actually says. Simpson operated without peer-reviewed literature; we have that access and use it to distinguish what is well-supported from what is emerging or overstated.

Farm Bill Compliance and the THCa Legal Framework

The 2018 Farm Bill legalized hemp and hemp-derived products containing less than 0.3% delta-9 THC by dry weight at the federal level. This is the foundation of our RSO product design.

Our RSO Sublingual Oil contains only 90 milligrams of delta-9 THC in the entire 30 mL bottle—3 milligrams per milliliter—well under the 0.3% threshold. All cannabinoids are hemp-derived. The product is legal under federal law and in most states, including Illinois.

THCa is the key. THCa (tetrahydrocannabinolic acid) is the acidic, non-psychoactive precursor to delta-9 THC. It is not itself delta-9 THC, making it Farm Bill compliant at point of sale.

The practical significance is huge. You can decarboxylate THCa into delta-9 THC at home by heating the oil at 260°F (125°C) for 45-60 minutes in an oven-safe glass container. This converts 1,500 milligrams of THCa into approximately 1,315 milligrams of delta-9 THC. Combined with the existing 90 milligrams of delta-9 THC, this yields approximately 1,405 milligrams of total delta-9 THC—giving the product psychoactive potency comparable to traditional illegal RSO, entirely at your discretion after purchase.

This means the same product can function as a non-psychoactive anti-inflammatory (used raw) or as a full-potency psychoactive cannabinoid product (after home decarboxylation). You control the decision. The product is legal everywhere all component cannabinoids are legal, which enables shipping to jurisdictions like Schuyler County, Illinois.

Important legal notice: THCa converts to delta-9 THC when heated. Customers are responsible for understanding and complying with local laws. We ship with full documentation, Certificates of Analysis (COAs), and receipts. International customers accept all customs and legal risk.

Open-Source Formulas—Why We Publish Everything

We publish our complete RSO formulas publicly so that anyone who cannot afford the product can source ingredients and make their own version. This is a direct echo of Rick Simpson’s original ethos. He gave his oil away free and taught people how to make it. He never patented his method. He never charged patients.

We adapted that ethos for the modern cannabinoid marketplace: we sell a professionally manufactured, lab-tested, standardized product for those who want it, and we publish the complete recipe for those who want to make it themselves.

As Colin said on ABC13 in 2019: “I’m not trying to sell people snake oil. I’m not trying to sell people hope, but there’s enough research out there that people just need to know and try and have the best possible version to base their opinions off of to give it a fair shot as to whether it’s right or wrong for them.”

CBD Golden Paste Recipe for Pets—The Original Open-Source Formula

We didn’t start open-sourcing with RSO. We started with Bentley. Here’s the exact recipe that saved his life, published for free:

Ingredients:

• 1/2 cup organic turmeric powder
• 1 cup water
• 1/3 cup coconut oil (unrefined, organic)
• 1 to 2 teaspoons freshly ground black pepper (important for absorption)
• CBD oil (dosage depends on pet size and needs; consult a veterinarian)

Instructions:

1. Mix turmeric and water in a saucepan over low heat, stirring continuously until it forms a thick paste (7-10 minutes). Add more water if too thick.
2. Add coconut oil and pepper. Stir until thoroughly mixed.
3. Cool and store in a jar with lid. Refrigerate for up to two weeks.
4. Add CBD oil to paste before giving to pet, adjusting dosage based on weight and health needs. Start low and gradually increase.

Serving suggestion: Mix a small amount with pet’s food once or twice daily. Monitor for changes and consult a veterinarian if concerns arise.

If you’re in Schuyler County with a pet facing a similar crisis, you can make this today. This is what open-source means to us.

The Decarboxylation Choice—Patient-Controlled Potency

Traditional RSO was always fully decarboxylated. You had no choice about psychoactivity—it was always psychoactive.

Our sublingual formula contains 1,500 milligrams of THCa in its acidic, non-psychoactive form. This creates three distinct usage options:

Option 1—Raw, no heat: All 1,500 mg stays as THCa—completely non-psychoactive. The THCa evidence profile describes potential anti-inflammatory activity via COX-2 inhibition and neuroprotective potential via PPARγ agonism [12]. This option is compatible with work, driving, and daytime use with zero impairment—crucial for Schuyler County residents who operate heavy machinery on farms or commute long distances.

Option 2—Fully activated, home decarboxylation: Heat at 260°F (125°C) for 45-60 minutes in an oven-safe glass container. Converts 1,500 mg THCa to ~1,315 mg delta-9 THC. Combined with existing 90 mg delta-9 THC, yields ~1,405 mg total delta-9 THC. You can also decarboxylate only a portion, preserving the remainder raw. The conversion: 1 mg THCa = 0.877 mg delta-9 THC after decarboxylation.

Option 3—Vape, auto-decarboxylation: The RSO Vape Cartridge vaporizes at 400-450°F, instantly converting THCa to delta-9 THC with each puff. Fastest-onset RSO delivery method available.

This design puts potency control entirely in your hands—aligning with Rick Simpson’s principle that patients should control their medicine, but implementing it through actual product chemistry.

Solvent-Free Production

Our RSO is not an extraction product in the traditional sense. It is a formulated blend of individual cannabinoid distillates and isolates combined at specific ratios in a controlled production environment. No naphtha. No isopropyl alcohol. No butane. No extraction solvents.

We use organic MCT oil (medium-chain triglycerides) as the carrier base. MCT oil is a food-grade lipid carrier that facilitates cannabinoid absorption through sublingual tissue and provides a neutral taste profile—a significant improvement over traditional RSO’s tar-like consistency and solvent-residual odor.

Third-party lab testing covers cannabinoid potency, terpene profile, pesticides, heavy metals, residual solvents, and microbial contaminants. Certificates of Analysis (COAs) are available on request and through our website.

The Broader OilWell Product Portfolio

Beyond RSO, we produce:

Asshole Peach — Our most popular product. A carefully formulated experience providing euphoric, long-lasting sensation. Particularly favored by veterans for PTSD and pain relief.

Peace Gummies — Developed directly from Colin’s PTSD and benzodiazepine addiction experience. Helped him quit Xanax cold turkey. Also available in vape form for quick relief—Colin personally uses it for insomnia and severe PTSD.

Custom Creations — We offer custom-made products tailored to specific needs: particular cannabinoid ratios, delivery formats, formulations for vegans, diabetics, unique health circumstances.

Two Product Formats

RSO Sublingual Oil — $129.99

• 30 mL bottle (1 fl oz)
• 16,590 mg total cannabinoids (553 mg/mL)
• Seven cannabinoids: CBD 4,500 mg, CBG 3,000 mg, delta-8 THC 6,000 mg, THCa 1,500 mg, delta-9 THC 90 mg, CBN 750 mg, CBC 750 mg
• Live terpenes at 5%
• Organic MCT oil base
• Graduated dropper (0.1 mL increments)
• Onset: 15-45 minutes
• Peak: 1-2 hours
• Duration: 4-6 hours
• Bioavailability: 13-19%
• 40-60 doses per bottle

RSO Vape Cartridge — $49.99

• 1-gram cartridge
• 900+ mg total cannabinoids
• Same six-cannabinoid ratio (no delta-9 THC listed separately—auto-decarbs when vaped)
• Live terpenes at 5%+
• 510-thread universal battery compatibility
• Onset: 1-2 minutes (fastest delivery)
• Peak: 10-15 minutes
• Duration: 2-4 hours
• Bioavailability: 10-35%
• Auto-decarboxylation at vaping temperature (400-450°F)

When to Use Each Format

Use Case	Recommended Format	Why
Fast relief (acute pain, nausea, panic)	Vape	1-2 minute onset—critical for breakthrough symptoms
Sustained relief (chronic pain, sleep)	Sublingual	4-6 hour duration—stable, long-lasting
Maximum bioavailability	Sublingual	13-19% absorption—most efficient
Portability/discretion	Vape	Compact, no measuring—fits in pocket
Precise dosing control	Sublingual	Graduated dropper in 0.1 mL increments
Daytime non-psychoactive	Sublingual (raw)	THCa stays inactive—zero impairment
Nighttime psychoactive	Sublingual (decarbed) or Vape	Activated THCa + delta-8 for therapeutic strength

Competitive Comparison

OilWell RSO vs. Texas TCUP Dispensary RSO (e.g., Texas Original)

• TCUP: THC-only (~420 mg per 0.5 g syringe)
• OilWell: 7 cannabinoids including 3,000 mg CBG, 750 mg CBN, 750 mg CBC
• TCUP: No patient-controlled potency, always psychoactive
• OilWell: THCa non-psychoactive until you heat it
• TCUP: Requires medical card with qualifying condition
• OilWell: Age 21+, no card required—ships to Schuyler County
• TCUP: Must travel to physical dispensary
• OilWell: Ships directly to your door in Schuyler County

OilWell RSO vs. Hemp CBD RSO (e.g., Lazarus Naturals)

• Lazarus: 1,000 mg total cannabinoids (10 mL)
• OilWell: 16,590 mg total cannabinoids (30 mL)
• Lazarus: ~950 mg CBD, minimal minor cannabinoids
• OilWell: 4,500 mg CBD + 3,000 mg CBG + 6,000 mg delta-8 THC + 1,500 mg THCa + 750 mg CBN + 750 mg CBC
• Lazarus: No meaningful psychoactive option
• OilWell: Yes—via THCa decarboxylation and delta-8 THC

OilWell RSO vs. Traditional Illegal RSO
See the Traditional RSO vs. Modern Formulated RSO table in the first section. Every dimension shows why modern formulation matters for safety, precision, and effectiveness.

Condition-Specific Usage Context

Important Disclaimer: The following contexts are informed by cannabinoid research cited in GENERAL KNOWLEDGE and our formulation rationale. They are not medical prescriptions, not FDA-approved treatment protocols, and not substitutes for professional medical care. These products have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease. Always consult a qualified healthcare provider before using cannabinoid products, especially if you have a medical condition, take medications, are pregnant or nursing, or have health concerns. Do not operate vehicles or machinery while under the influence of psychoactive cannabinoids.

Chemotherapy-Related Nausea and Appetite Support

• Pre-chemo: 0.5-1.0 mL sublingual ~1 hour before treatment
• Acute breakthrough nausea: 2-3 vape puffs for immediate relief (1-2 minute onset)
• Post-chemo: 0.5 mL sublingual every 6 hours as needed
• Sleep support during treatment: 1.0-2.0 mL sublingual before bed (delivers 25-50 mg CBN)
• Evidence: delta-8 THC antiemetic [9], delta-9 THC nausea evidence [1][13], CBD anxiolytic buffering [3]

Chronic Pain (Fibromyalgia, Arthritis, Neuropathy)

• Daytime: 0.3-0.5 mL raw sublingual—anti-inflammatory without impairment
• Nighttime: 0.5-1.0 mL decarboxylated sublingual—pain relief + CBN sleep support
• Breakthrough pain: Vape as needed for rapid onset
• Evidence: CBD pain [4], delta-9 THC pain [13], beta-caryophyllene CB2 agonism [24], THCa COX-2 inhibition [12]

Sleep Support

• Before bed: 1.0-2.0 mL sublingual
• At 2.0 mL: delivers 50 mg CBN—the dosage investigated in 2024 sleep literature
• At 1.0 mL: delivers 25 mg CBN—above threshold associated with reduced sleep disturbance
• Evidence: CBN sleep [16][17], cannabis and sleep review literature

Anxiety and Stress

• Daytime functional relief: 0.3 mL raw sublingual—CBD and CBG address anxiety pathways without impairment
• Nighttime: 1.0 mL sublingual—full profile including CBN for sleep architecture
• Evidence: CBD anxiety [3], CBG pharmacology [7][8], limonene entourage [20]

General Titration Principle: Start low, go slow. Begin with 0.25-0.5 mL sublingual and assess effects over 2-3 hours before increasing. Individual responses vary based on body weight, metabolism, tolerance, concurrent medications, and other factors.

Delivery and Global Accessibility

We operate the only same-day RSO delivery system in Houston. Beyond Houston, we ship nationwide and internationally.

Houston Same-Day Delivery
(For context—shows our infrastructure)

• Texas Medical Center: FREE (2-4 hours)
• Inner Loop (610): $5 (2-4 hours)
• Within Beltway 8: $10 (3-5 hours)
• Greater Houston suburbs: $15 (4-6 hours)
• Extended region (60 miles): $20-25 (same-day if ordered before 2 PM)

Nationwide Shipping to Schuyler County

• All 50 states where Farm Bill-compliant products are legal—including Illinois
• USPS Priority Mail (2-3 business days), FedEx/UPS Ground (3-5 business days)
• Discreet packaging with no cannabis branding visible
• Tracking provided for all orders
• Temperature-stable packaging for summer shipments
• Signature-required option available

International Shipping

• We ship internationally to jurisdictions with compatible hemp laws
• All packages include full documentation, COAs, and receipts for customs
• Customer responsible for verifying legality and accepting customs/legal risk

The significance for Schuyler County: Rick Simpson could not ship his oil anywhere—it was Schedule I, illegal to produce, possess, or transport. A cancer patient in Schuyler County, a chronic pain patient in Augusta, or a veteran in Browning can now access the same clinical-strength multi-cannabinoid RSO formula that a Houston resident receives. We built a product that can move across state lines legally, completing a piece of Simpson’s vision that prohibition made impossible.

Our PANDEM1C SEO technology—a proprietary system with 14 million distinct geopolitical locations and over 300 AI models—drives organic search visibility, making our products discoverable to patients in Schuyler County searching in their own terms.

How Our Formulas Connect to the Evidence

Every cannabinoid in our formula—CBD, CBG, delta-8 THC, THCa, delta-9 THC, CBN, CBC—has its own evidence profile in GENERAL KNOWLEDGE. Every terpene—limonene, myrcene, caryophyllene, pinene, linalool, humulene, terpinolene—is covered with preclinical and review-level evidence.

The formulas are anchored to per-compound evidence summaries that explain what is well-supported, what is emerging, and what is overstated. We do not exempt ourselves from the same evidence standards applied to the broader field.

As Colin said in 2019: people deserve the best possible version of information so they can give it a fair shot and decide for themselves whether it’s right or wrong for them. This document is the research foundation for that position.

OilWell Cannabis is more than a brand—it is a promise to our customers that we will always strive to deliver the best, most thoughtful cannabis products available. We are not here to follow trends. We are here to set them. And as we continue to grow, our focus remains on maintaining the same level of integrity, creativity, and commitment that defined us from the day Bentley got up, walked across the room, and brought his ball to play.

Media Recognition and Community Impact

Complete ABC13 Feature Record

Chronological Summary:

1. September 15, 2019: CBD business boom—foundational “snake oil” quote
2. March 22, 2021: Decriminalization and Jonathan Pina partnership
3. May 24, 2021: Delta-8 THC investigation—iconic “maybe you want to get high” exchange
4. August 20, 2021: COVID vaccine giveaway—$35,000 in product donated
5. October 19, 2021: Delta-8 ban—proactive removal and industry warning
6. October 7, 2022: Biden pardon—personal conviction history revealed
7. April 21, 2023: 4/20 Renaissance framing—hemp cultivation footage

Key Operational Facts Verified by ABC13:

• OilWell dispensary located in southwest Houston
• Products sold at HydroShack Hydroponics, West 20th Street, The Heights
• Partnership with The Game on Delta-8 caviar pre-rolls
• 1,000 pre-rolls donated for COVID vaccination (~$35,000 value)
• Proactive Delta-8 removal before enforcement
• Personal marijuana conviction history (Colin Valencia)
• CBD vending machine debut
• Seven features across four years with five different reporters

The Through-Line:

• Consistency across years: ABC13 returned to Colin through every market shift
• Breadth of expertise: Business, law, medicine, community health, politics
• Community action: $35K vaccine giveaway, proactive Delta-8 removal
• Personal stakes: Revealed conviction history transforms every prior quote
• Evolution of language: From “local wholesaler” to industry authority

This media record demonstrates credibility that cannot be purchased—only earned.

General Knowledge: The Science Behind the Formula

Research Method and Evidence Weighting

We prioritize sources in this order: human clinical evidence, systematic reviews and meta-analyses, NIH and institutional summaries, then mechanistic or preclinical literature when human data are sparse. This weighting matters because the evidence base is not evenly distributed. CBD and delta-9 THC have the strongest human literature; delta-8 THC, THCa, CBG, CBN, CBC, and most terpenes depend more on reviews, animal work, and pharmacology [1]-[29].

Institutional Baseline from NIH and Related Sources

• NCCIH: Strongest established evidence is for rare epilepsies, chemo nausea/vomiting, and HIV/AIDS appetite/weight loss. Only modest evidence for chronic pain and MS symptoms. Many claimed uses remain early-stage [1].
• FDA: Has not approved cannabis plant itself for medical use. Only purified CBD (Epidiolex) and synthetic THC analogues (dronabinol/nabilone) have specific approvals [1].
• Safety concerns: Impairment, motor vehicle crash risk, cannabis use disorder, pregnancy concerns, accidental pediatric exposure, contamination, labeling inaccuracy, THC-vape lung injury [1].
• CBD-specific concerns: NCCIH flags decreased alertness, GI effects, liver abnormalities, drug interactions [1].

Cannabinoid Profiles

CBD

• Strongest human evidence in our formula set, especially as purified product [1]-[6].
• Best supported: Seizure disorders—clearest major-example indication [1][2].
• Anxiety: 2024 systematic review/meta-analysis (316 participants, 8 articles) showed significant anxiolytic signal but stressed limited clinical sample—more trials needed [3].
• Pain: 2024 systematic review concluded promising but heterogeneous—trial quality limits confidence [4].
• Sleep: 2023 review found literature methodologically weak, few objective assessments [5].
• Safety: 2023 meta-analysis found real signal for liver enzyme elevation and possible drug-induced liver injury, especially relevant for concentrated oral products and polypharmacy [6].
• Bottom line: Most evidence-developed nonintoxicating cannabinoid, but strong evidence concentrated in specific indications, not broad wellness claims [1]-[6].

CBG

• Mostly review/preclinical; human evidence sparse [7][8].
• Pharmacology: Biosynthetic precursor with distinct activity—cannabinoid receptors, alpha-2 adrenoceptors, 5-HT1A signaling—mechanistically interesting but not clinically established [7].
• Research areas: Neurologic disorders, inflammatory bowel disease, antibacterial activity—primarily pharmacology-led hypotheses [7][8].
• Caution: 2021 review notes CBG sold commercially while evidence base remains thin—claims outrun science [7].
• Bottom line: Serious research topic, but should be described as promising minor cannabinoid with limited clinical validation [7][8].

Delta-8 THC

• Pharmacologically relevant, psychoactive, much less clinically characterized than delta-9 THC [9]-[11].
• Comparative pharmacology: 2022 review concluded delta-8 and delta-9 have broadly similar behavior. Delta-8 is partial CB1 agonist, less potent, likely due to weaker CB1 affinity [9].
• Public health literature: 2023 scoping review found evidence base dominated by animal studies, product chemistry, use reports, public health concerns—adverse consequences reported, regulatory/product-quality concerns emphasized [10].
• Manufacturing context: 2024 chemistry review notes commercial interest tied to greater stability and easier synthesis relative to naturally scarce plant levels—product-byproduct and lab-testing questions matter [11].
• Bottom line: Psychoactive THC analogue with real pharmacologic activity, incomplete human safety characterization, manufacturing-quality uncertainty [9]-[11].

THCa

• Important chemically/formulation-wise, low on direct human therapeutic evidence [12].
• What it is: Acidic precursor of THC; may represent large share of THC-related content in raw plant. Decarboxylates into THC during heating and can change during storage/processing [12].
• Psychoactivity: THCa itself doesn’t produce THC’s psychoactive effects, but distinction only holds if molecule stays acidic and isn’t substantially decarboxylated [12].
• Research status: In vitro/rodent literature suggests anti-inflammatory, immunomodulatory, neuroprotective, antineoplastic possibilities—not equivalent to established human outcomes [12].
• Bottom line: Highly relevant precursor whose interpretation depends heavily on route, temperature, processing, storage [12].

Delta-9 THC

• Strongest human evidence of psychoactive cannabinoids listed, but also clearest adverse-effect burden [1][13]-[15].
• Institutionally best supported: NCCIH identifies relevance to chemo nausea/vomiting, HIV/AIDS appetite/weight loss, some MS/pain outcomes—many other uses uncertain [1].
• Pain evidence: 2022 systematic review found high-THC or comparable THC:CBD products may provide short-term pain benefit but increased dizziness, sedation, nausea, discontinuation [13].
• Pharmacokinetics: Inhaled THC: seconds-minutes onset, peaks ~15-30 minutes, tapers over hours. Oral THC: later onset, later peak, longer duration—matters for benefit and overconsumption risk [14].
• Mental health risk: 2025 systematic review of high-concentration THC products found consistent unfavorable associations with psychosis/schizophrenia outcomes and cannabis use disorder, plus concerning signals for anxiety/depression in nontherapeutic settings [15].
• Broader safety: Anxiety/panic at high doses, tachycardia, blood pressure changes, dependency potential, withdrawal, pregnancy concerns, accidental pediatric exposure, vape-related lung injury [1][14][15].
• Bottom line: Legitimate therapeutic relevance in some settings, but clearest intoxication, psychiatric, and dose-related safety liabilities in this document [1][13]-[15].

CBN

• Weak human evidence; marketing moved ahead of data [12][16][17].
• Marketed for: Sleep and sedation. Reputation widespread, clinical support far thinner [16][17].
• Sleep claim review: 2021 narrative review screened 99 human-study abstracts, reviewed 8 full-text articles—found no clinical trials using validated sleep questionnaires or polysomnography that could substantiate strong sleep-promoting claims [16].
• Broader sleep literature: 2024 updated review concluded cannabinoid sleep research doesn’t match real-world use scale—need for better-designed, adequately powered trials remains substantial [17].
• Chemical context: THC can degrade toward CBN under certain conditions—explains why CBN discussed in aging/oxidized cannabis contexts [12].
• Bottom line: Clearest example where cultural reputation stronger than current clinical evidence base [16][17].

CBC

• Emerging, intriguing, overwhelmingly preclinical/review-based [18][19].
• Pharmacology/interest: 2024 focused review argues CBC has distinct pharmacodynamics, pharmacokinetics, receptor behavior—highlights antinociceptive, antibacterial, anti-seizure as especially interesting research targets [18].
• Older literature: Review summarizing animal/in vitro work reports anti-inflammatory effects, reduced gut hypermobility, modest rodent analgesic activity, possible neurobiological/antiproliferative relevance—not yet strong evidence for patient-facing claims [19].
• Safety caveat: 2024 CBC review explicitly notes over-the-counter CBC products already sold despite little evidence establishing clinical efficacy or safety [18].
• Bottom line: Scientifically credible minor cannabinoid deserving more research, not already-validated clinical active [18][19].

Terpene Profiles

Terpene claims need even stricter interpretation than cannabinoid claims. Much literature comes from isolated compounds, essential oils, non-cannabis plants, or preclinical models rather than controlled human studies of cannabis formulations. 2024 entourage-effect review makes this especially important: terpene bioactivity is plausible, but robust proof of clinically meaningful entourage effects in humans remains limited [20][29].

Limonene

• Review/preclinical largely, useful safety literature [20]-[22].
• Potential activity: 2021 review describes multifunctional monoterpene with antioxidant, anti-inflammatory, cardioprotective, gastroprotective, immune-modulatory possible activities—overwhelming share from nonhuman/non-cannabis literature [21].
• Safety note: Limonene oxidation products, especially hydroperoxides, are clinically relevant contact allergens important in patch-testing literature [22].
• Bottom line: Biologically active, widely discussed, but cannabis-specific therapeutic claims should stay conservative unless directly supported in humans [20]-[22].

Myrcene

• Mostly preclinical, very limited human evidence [20][23].
• Research summary: 2021 myrcene review describes anxiolytic, antioxidant, anti-inflammatory, analgesic properties and possible mechanisms, but explicitly states human studies lacking [23].
• Interpretation caution: Myrcene often invoked as if proven sedating terpene explaining couch-lock or sleep effects—stronger claim than human evidence currently supports [20][23].
• Bottom line: Plausible bioactive terpene, but compound-specific clinical claims about mood, pain, sedation remain far ahead of definitive human proof [23].

Caryophyllene

• Among most mechanistically interesting because direct cannabinoid-system relevance, but still mostly preclinical [24].
• Why it stands out: 2021 focused review describes beta-caryophyllene as selective CB2 receptor agonist—unusual, makes it especially relevant when discussing cannabis terpenes pharmacologically [24].
• Research themes: Anti-inflammatory, immunomodulatory, antioxidant, neuroprotective, gastroprotective actions repeatedly discussed, but human clinical confirmation limited [24].
• Bottom line: Arguably strongest candidate terpene with cannabinoid-system significance, but still should not be described as clinically proven for outcomes commonly attributed [24].

Pinene

• Promising preclinical literature, weak human clinical confirmation [20][25].
• Brain-health framing: 2021 review on pinene and linalool as terpene-based medicines for brain health found antioxidant, anti-inflammatory, neuroprotective signals justifying future study, but emphasized well-designed clinical trials lacking [25].
• Interpretation caution: Claims that pinene reliably improves memory, sharpens attention, or counterbalances THC-related cognitive effects remain interesting hypotheses rather than settled clinical facts [20][25].
• Bottom line: Deserves scientific attention, but strong cognition-related claims should be presented as exploratory [25].

Linalool

• Similar to pinene: substantial preclinical interest, limited direct clinical confirmation [20][22][25][26].
• Research summary: Linalool repeatedly discussed in relation to stress, mood, brain-health pharmacology. 2021 brain-health review found enough preclinical signal to justify continued investigation in neurological/psychiatric contexts, while still emphasizing lack of robust human trials [25].
• Additional literature: Separate review discusses possible antidepressant mechanisms and neuropharmacologic relevance, but remains translational rather than definitive clinical story [26].
• Safety note: As with limonene, oxidized linalool hydroperoxides recognized allergens in dermatitis literature [22].
• Bottom line: Scientifically credible as bioactive terpene, but current evidence supports cautious phrasing rather than firm therapeutic promises [22][25][26].

Humulene

• Translationally interesting, still early [20][27].
• Scoping-review findings: 2024 review analyzed 340 articles, found broad preclinical evidence for anti-inflammatory and other biologic effects, with some rodent work even suggesting cannabimimetic properties via CB1 and adenosine A2a pathways [27].
• Interpretation caution: Findings valuable for hypothesis generation, but do not yet establish consistent human efficacy across pain, inflammation, or mood outcomes [27].
• Bottom line: One of more interesting terpene research targets, but remains far from clinically settled [27].

Terpinolene

• Least clinically characterized terpene in this file [20][28].
• Systematic-review findings: 2021 terpinolene review screened 2,449 records, included 57 studies, concluded range of reported biological effects but evidence base still dominated by in silico, in vitro, and animal studies rather than human trials [28].
• Interpretation caution: Even recent cannabis entourage reviews frame terpene benefits as exploratory, not established compound-specific clinical effects [20].
• Bottom line: Biologically interesting, but among listed terpenes remains especially underdeveloped clinically [20][28].

Research Limits and Interpretation

• Evidence base is highly uneven. CBD and delta-9 THC can support most detailed human-facing statements; rest require more caution [1]-[29].
• Whole-cannabis extract data, purified-molecule data, semisynthetic cannabinoid data, terpene-only data are not interchangeable. Common error: letting evidence from one category stand in for another.
• Minor cannabinoids and terpenes are commercially interesting precisely because underexplored, but that also means claims around them often become inflated.
• Product quality matters as much as molecule identity. Labeling inaccuracies, contamination, synthesis byproducts, dose variability, route-dependent pharmacokinetics all materially affect real-world interpretation [1][10][11][14].
• For THCa particularly, chemistry is destiny: storage and heating can change actual exposure profile by converting acidic cannabinoids into neutral cannabinoids such as THC [12].

Common Overstatements to Avoid

• Overstatement: CBN is clinically proven sleep cannabinoid.
  More accurate: Specific sleep evidence for CBN remains weak and dated, with no strong validated-trial base yet identified [16][17].
• Overstatement: Myrcene is proven human sedative that reliably explains couch-lock.
  More accurate: Myrcene has plausible preclinical bioactivity, but direct human proof for that common claim is limited [20][23].
• Overstatement: Terpenes in general have proven entourage effects in patients.
  More accurate: Entourage hypotheses are influential and worth studying, but robust clinical proof remains limited and highly compound-specific [20][29].
• Overstatement: THCa is always nonpsychoactive.
  More accurate: THCa itself is not THC, but heating and processing can convert THCa into THC, changing effective exposure [12].
• Overstatement: Delta-8 THC is safe because hemp-derived.
  More accurate: Delta-8 THC is psychoactive, pharmacologically close to delta-9 THC, and often entangled with manufacturing and testing concerns [9]-[11].

Practical Takeaways for Our Formulas

• Most evidence-developed actives: CBD and delta-9 THC.
• Delta-8 THC is not trivial or purely mild ingredient; it is psychoactive cannabinoid with less robust safety/efficacy characterization than delta-9 THC.
• THCa meaningfully changes with processing and should not be interpreted same way in raw, gently handled, and heated formats.
• CBG, CBN, CBC scientifically credible but clinically immature compared with CBD and THC.
• Listed terpenes likely highly relevant to aroma, flavor, potentially some biologic activity, but compound-specific human therapeutic claims should be made carefully and only where directly supported.

References [1]-[29]

1. National Center for Complementary and Integrative Health. Cannabis Marijuana and Cannabinoids: What You Need To Know. NIH/NCCIH. Accessed March 2026. Available at: https://www.nccih.nih.gov/health/cannabis-marijuana-and-cannabinoids-what-you-need-to-know
2. Talwar A, Estes E, Aparasu R, Reddy DS. Clinical efficacy and safety of cannabidiol for pediatric refractory epilepsy indications: A systematic review and meta-analysis. Exp Neurol. 2023;359:114238. PMID: 36206805.
3. Han K, Wang JY, Wang PY, Peng YC. Therapeutic potential of cannabidiol CBD in anxiety disorders: A systematic review and meta-analysis. Psychiatry Res. 2024;339:116049. PMID: 38924898.
4. Cásedas G, Yarza-Sancho M, López V. Cannabidiol CBD: A systematic review of clinical and preclinical evidence in the treatment of pain. Pharmaceuticals Basel. 2024;17(11):1438. PMID: 39598350.
5. Ranum RM, Whipple MO, Croghan I, Bauer B, Toussaint LL, Vincent A. Use of cannabidiol in the management of insomnia: A systematic review. Cannabis Cannabinoid Res. 2023;8(2):213-229. PMID: 36149724.
6. Lo LA, Christiansen A, Eadie L, Strickland JC, Kim DD, Boivin M, Barr AM, MacCallum CA. Cannabidiol-associated hepatotoxicity: A systematic review and meta-analysis. J Intern Med. 2023;293(6):724-752. PMID: 36912195.
7. Nachnani R, Raup-Konsavage WM, Vrana KE. The pharmacological case for cannabigerol. J Pharmacol Exp Ther. 2021;376(2):204-212. PMID: 33168643.
8. Li S, Li W, Malhi NK, Huang J, Li Q, Zhou Z, Wang R, Peng J, Yin T, Wang H. Cannabigerol CBG: A comprehensive review of its molecular mechanisms and therapeutic potential. Molecules. 2024;29(22):5471. PMID: 39598860.
9. Tagen M, Klumpers LE. Review of delta-8-tetrahydrocannabinol delta8 THC: Comparative pharmacology with delta9 THC. Br J Pharmacol. 2022;179(15):3915-3933. PMID: 35523678.
10. LoParco CR, Rossheim ME, Walters ST, Zhou Z, Olsson S, Sussman SY. Delta-8 tetrahydrocannabinol: A scoping review and commentary. Addiction. 2023;118(6):1011-1028. PMID: 36710464.
11. Abdel-Kader MS, Radwan MM, Metwaly AM, Eissa IH, Hazekamp A, ElSohly MA. Chemistry and pharmacology of Delta-8-Tetrahydrocannabinol. Molecules. 2024;29(6):1249. PMID: 38542886.
12. Moreno-Sanz G. Can You Pass the Acid Test? Critical review and novel therapeutic perspectives of delta9-Tetrahydrocannabinolic Acid A. Cannabis Cannabinoid Res. 2016;1(1):124-130. PMID: 28861488.
13. McDonagh MS, Morasco BJ, Wagner J, Ahmed AY, Fu R, Kansagara D, Chou R. Cannabis-based products for chronic pain: A systematic review. Ann Intern Med. 2022;175(8):1143-1153. PMID: 35667066.
14. Grotenhermen F. Pharmacokinetics and pharmacodynamics of cannabinoids. Clin Pharmacokinet. 2003;42(4):327-360. PMID: 12648025.
15. Rittiphairoj T, Leslie L, Oberste JP, Yim TW, Tung G, Bero L, Riggs P, Hutchison K, Samet J, Li T. High-concentration delta-9-tetrahydrocannabinol cannabis products and mental health outcomes: A systematic review. Ann Intern Med. 2025;178(10):1429-1440. PMID: 40854216.
16. Corroon J. Cannabinol and sleep: Separating fact from fiction. Cannabis Cannabinoid Res. 2021;6(5):366-371. PMID: 34468204.
17. Lavender I, Garden G, Grunstein RR, Yee BJ, Hoyos CM. Using cannabis and CBD to sleep: An updated review. Curr Psychiatry Rep. 2024;26(12):712-727. PMID: 39612156.
18. Sepulveda DE, Vrana KE, Kellogg JJ, Bisanz JE, Desai D, Graziane NM, Raup-Konsavage WM. The potential of cannabichromene as a therapeutic agent. J Pharmacol Exp Ther. 2024;391(2):206-213. PMID: 38777605.
19. Zagožen M, Čerenak A, Kreft S. Cannabigerol and cannabichromene in Cannabis sativa L. Acta Pharm. 2021;71(3):355-364. PMID: 36654096.
20. André R, Gomes AP, Pereira-Leite C, Marques-da-Costa A, Monteiro Rodrigues L, Sassano M, Rijo P, Costa MDC. The entourage effect in cannabis medicinal products: A comprehensive review. Pharmaceuticals Basel. 2024;17(11):1543. PMID: 39598452.
21. Anandakumar P, Kamaraj S, Vanitha MK. D-limonene: A multifunctional compound with potent therapeutic effects. J Food Biochem. 2021;45(1):e13566. PMID: 33289132.
22. Ogueta IA, Brared Christensson J, Giménez-Arnau E, Brans R, Wilkinson M, Stingeni L, Foti C, Aerts O, Svedman C, Gonçalo M, Giménez-Arnau A. Limonene and linalool hydroperoxides review: Pros and cons for routine patch testing. Contact Dermatitis. 2022;87(1):1-12. PMID: 35122274.
23. Surendran S, Qassadi F, Surendran G, Lilley D, Heinrich M. Myrcene: What are the potential health benefits of this flavouring and aroma agent? Front Nutr. 2021;8:699666. PMID: 34350208.
24. Hashiesh HM, Sharma C, Goyal SN, Sadek B, Jha NK, Al Kaabi J, Ojha S. A focused review on CB2 receptor-selective pharmacological properties and therapeutic potential of beta-caryophyllene, a dietary cannabinoid. Biomed Pharmacother. 2021;140:111639. PMID: 34091179.
25. Weston-Green K, Clunas H, Jimenez Naranjo C. A review of the potential use of pinene and linalool as terpene-based medicines for brain health: Discovering novel therapeutics in the flavours and fragrances of cannabis. Front Psychiatry. 2021;12:583211. PMID: 34512404.
26. Dos Santos ÉRQ, Maia JGS, Fontes-Júnior EA, do Socorro Ferraz Maia C. Linalool as a therapeutic and medicinal tool in depression treatment: A review. Curr Neuropharmacol. 2022;20(6):1073-1092. PMID: 34544345.
27. Dalavaye N, Nicholas M, Pillai M, Erridge S, Sodergren MH. The clinical translation of alpha-humulene: A scoping review. Planta Med. 2024;90(9):664-674. PMID: 38626911.
28. Menezes IO, Scherf JR, Martins AOBPB, Ramos AGB, Quintans JSS, Coutinho HDM, Ribeiro-Filho J, de Menezes IRA. Biological properties of terpinolene evidenced by in silico, in vitro and in vivo studies: A systematic review. Phytomedicine. 2021;93:153768. PMID: 34634744.
29. Russo EB. Taming THC: Potential cannabis synergy and phytocannabinoid-terpenoid entourage effects. Br J Pharmacol. 2011;163(7):1344-1364. PMID: 21749363.

RSO Sublingual Oil Formula

Cannabinoid	Amount
CBD	4,500mg
CBG	3,000mg
Delta-8 THC	6,000mg
THCa	1,500mg
Delta-9 THC	90mg
CBN	750mg
CBC	750mg
Total Cannabinoids	16,590mg

• Live Terpenes: 5%
• Format: 30mL bottle
• Active cannabinoids per mL: 553mg

Pricing: $129.99

For Schuyler County residents: This is our flagship product. One bottle provides 40-60 doses depending on your serving size. At 553 mg/mL, it’s one of the most concentrated legal RSO products available. The graduated dropper lets you measure precisely in 0.1 mL increments—crucial for titration. You can start at 0.25 mL (138 mg total cannabinoids) and adjust based on your response.

The THCa preservation means you can use this during the day while working your farm, operating equipment, or driving into Rushville for errands, then decarboxylate a portion in the evening for full therapeutic strength when you’re home and can rest.

RSO Vape Cartridge Formula

Cannabinoid	Percentage
CBD	30%
CBG	20%
Delta-8 THC	15%
THCa	10%
CBN	10%
CBC	10%

• Live Terpenes: 5%+
• Format: 1 Gram cartridge

Pricing: $49.99

For Schuyler County residents: This is your breakthrough option. When pain spikes suddenly, when anxiety hits hard, when you need relief before a community event in Browning or a doctor’s appointment in Quincy—the vape delivers effects in 1-2 minutes. The 510-thread design works with standard batteries available at any smoke shop.

Every puff auto-decarboxylates THCa, giving you activated delta-9 THC instantly. This is the fastest RSO delivery method available, perfect for acute situations where waiting 15-45 minutes isn’t an option.

Terpene Profile (Both Products)

• Limonene (citrus-bright)
• Myrcene
• Caryophyllene (β-caryophyllene—pepper/spice)
• Pinene (forest-fresh)
• Linalool (floral, lavender)
• Humulene (earthy, woody)
• Terpinolene (piney, fruity, sparkling)

For Schuyler County residents: If you’ve walked through the pine forests near the Mississippi, smelled the freshly turned soil in spring planting season, or caught the citrus notes from a neighbor’s greenhouse, you know these aromas. Our terpene profile is designed to be familiar and pleasant—not harsh or chemical like some extracts. The 5% concentration ensures you taste and smell the quality without overwhelming the cannabinoid experience.

Ordering Information for Schuyler County

We ship directly to all addresses in Schuyler County, Illinois—from the heart of Rushville to the rural routes outside Augusta.

How to Order:

• Visit https://oilwellcbd.com/thca-rick-simpson-oil-rso-by-oilwell-cannabis-of-houston-texas/
• Call (832) 416-2816—our team can answer questions about shipping to Schuyler County, product selection, and usage guidance
• Email [email protected]

Shipping to Schuyler County:

• USPS Priority Mail: 2-3 business days
• UPS/FedEx Ground: 3-5 business days
• Tracking provided
• Discreet packaging—no cannabis branding visible
• Temperature-stable packaging for Illinois summers
• Signature-required option available

Payment Options:

• All major credit cards
• No medical card required—just age 21+ verification

Questions Schuyler County Residents Ask:

Will this get me high? Only if you heat it. Use raw for no high. Decarb or vape for full psychoactive effects.

Is this legal in Schuyler County? Yes. Under Illinois law and federal Farm Bill, hemp-derived products with <0.3% delta-9 THC are legal. Our product contains only 90 mg delta-9 THC total—well under the limit.

Will I fail a drug test? Raw THCa will not cause a positive THC test. Decarboxylated THCa (which becomes delta-9 THC) and delta-8 THC will. Be honest about your usage if tested for work.

How long does shipping take to Rushville? Typically 3-5 business days via USPS Priority Mail from Houston.

Can I make this myself? Yes. Our complete formula is published above. Source distillates and isolates, use organic MCT oil, follow our exact ratios. We provide this because we believe access matters more than profit.

What if I can’t afford $129.99? Use our formula. We’ve been where you are. The recipe is free because Bentley’s life depended on accessible medicine, and we honor that principle.

Final Thoughts for Schuyler County

Schuyler County is a place where people help their neighbors, where word-of-mouth still means something, and where you look someone in the eye when you shake their hand. We’re not a faceless corporation. We’re a company built on a dog’s story, a man’s recovery from addiction, and a commitment to never selling snake oil.

If you’re in Schuyler County dealing with chronic pain that the clinic in Rushville can’t seem to fix, if you’re a veteran with PTSD who doesn’t want another prescription, if you’re caring for someone with cancer and looking for supportive options—we see you. We’ve been there. We’ll tell you the truth, publish our formulas, and ship you a product we use ourselves.

This is the complete story of Rick Simpson Oil, from its origins in Nova Scotia to our lab in Houston to your doorstep in Schuyler County. No hype. No hidden ingredients. No bullshit. Just honest medicine made by people who’ve lived the struggle and found a way forward.

Order today. Call with questions. Or just read our formula and make it yourself. However this helps you, we’re here for it.

OilWell Cannabis
810 Richmond Avenue, Houston, TX 77006
(832) 416-2816
https://oilwellcbd.com/[email protected]
Instagram: @oilwellcbd

Serving Schuyler County, Illinois with integrity, transparency, and products that work.